Thai researchers have made an advancement by developing a rubber serum for medical use, showing potential in combating ...

For the quarter ended March 31, 2025, Edesa reported a net loss of $1.6 million, or $0.30 per common share, compared to a net ...

NSF fellows are considered future knowledge experts who will go on to become lifelong leaders, innovators and teachers.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Shares of Septerna Inc. were soaring in Wednesday trading after the biotech clinched a partnership with Wegovy and Ozempic parent Novo Nordisk to collaborate on oral obesity and Type 2 diabetes ...

Dr Singh described India as the emerging global biotech destination and said that this is the most appropriate venue for such ...

Nearly 600 attendees learned about life sciences industry trends and heard from 93 presenting biotechnology companies at ...

Results from a Phase 1 study of GT-02287 in healthy volunteers demonstrated favorable safety and tolerability, plasma and CNS ...

GEN talked with several contract development and manufacturing organizations (CDMOs) and/or contract research organizations (CROs) about new ways they are addressing AAV manufacturing challenges.

Ribonucleic acid, also called RNA, is a molecule present in all living cells. It plays a critical role in transmitting ...

Current setbacks cannot prevent gene-editing companies from advancing closer to “one-and-done” cures and new products.

Under the terms of the agreement, Septerna is eligible to receive around $2.2 billion from Novo Nordisk, including more than $200 million in upfront and near-term milestone payments.